Orikine Bio
Barcelona · Founded 2022
About Orikine Bio
Orikine Bio is a pioneer biotech company in the field of tailored cytokines with unmatched biological properties for the treatment of immune-mediated disorders.
Company Facts
- Founded: 2022
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $10.2M
- Funding stage: Seed
- Last round: Seed (Feb 2026)
- Website: https://www.orikine.bio
- Phone: +34 93 402 02 50
Industries & Categories
Biotechnology, Medical, Product Research
Social Profiles
Canonical: https://fsome.com/organization/orikine-bio-35928 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.